{"id":"W2978592627","doi":"10.1056/nejmoa1900408","title":"Ligelizumab for Chronic Spontaneous Urticaria","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Université Laval; University of Toronto; Centre hospitalier universitaire de Québec; St. Michael's Hospital","funders":"Novartis Pharma","keywords":"Medicine; Omalizumab; Placebo; Angioedema; Clinical endpoint; Internal medicine; Hereditary angioedema; Randomization; Chronic urticaria; Mallinckrodt; Gastroenterology; Randomized controlled trial; Immunoglobulin E; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001207457,0.0006644771,0.001032799,0.0002624514,0.0002485858,0.0003422065,0.0003841089,0.0006040343,0.005557802],"category_scores_gemma":[0.0007124087,0.0002186344,0.0006936028,0.0002003123,0.0003833612,0.0002549413,0.0001817819,0.001084952,0.0008676126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004543519,"about_ca_system_score_gemma":0.0006147716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001592432,"about_ca_topic_score_gemma":0.000445211,"domain_scores_codex":[0.9996719,0.0001439824,0.00003347951,0.00004708081,0.0000387882,0.00006481172],"domain_scores_gemma":[0.9995708,0.0001306387,0.0001285961,0.00003354304,0.00002200908,0.0001143887],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.462306,0.02052382,0.01369596,0.005168992,0.001822573,0.001154167,0.000160258,0.001135985,0.05861691,0.0008986987,0.006574788,0.4279418],"study_design_scores_gemma":[0.7727959,0.1817375,0.02498694,0.0001939084,0.000499395,0.002417387,0.00002631744,0.0007421921,0.005964097,0.0003278875,0.01028939,0.00001891909],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667487,0.0234176,0.001405591,0.001207075,0.0004119987,0.00254343,0.0005127375,0.0001920331,0.003560695],"genre_scores_gemma":[0.9883505,0.004511061,0.001383578,0.0009316166,0.0004129488,0.001826183,0.0005719729,0.00001263711,0.001999429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005557802,"threshold_uncertainty_score":0.01859272,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01062272350032795,"score_gpt":0.2661844055229041,"score_spread":0.2555616820225762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}